CLASS II Drug recall · Reported 18 Apr 2018 · FDA Enforcement Report
Conzerol zero molluscum contagiosum, Topical Cream recalled
Elroselabs is recalling Conzerol zero molluscum contagiosum, Topical Cream, distributed nationwide in the US. The recall was initiated on 28 Mar 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0621-2018
- FDA event ID
- 79606
- Recalling firm
- Elroselabs, Sanford, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 28 Mar 2018
- FDA classified
- 6 Apr 2018
- Reported
- 18 Apr 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Creams, Ointments & Gels
Timeline
| 28 Mar 2018 | Recall initiated by company | |
| 6 Apr 2018 | Classified by FDA | +9 days |
| 18 Apr 2018 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP Deviations
Product as listed by the FDA
Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06
Where it was distributed
Nationwide.
Questions about this recall
Is Conzerol zero molluscum contagiosum, Topical Cream recalled?
Yes. Elroselabs recalled Conzerol zero molluscum contagiosum, Topical Cream on 28 Mar 2018. The recall is Class II and its status is Terminated. Recall number D-0621-2018.
Why was it recalled?
cGMP Deviations
Which lots are affected?
All product within expiry
Where was it sold?
Nationwide.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Elroselabs
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Conzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3% tube recalled | Elroselabs | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Molleave, 2 oz bottle, OTC recalled by Elroselabs | Elroselabs | Manufacturing (CGMP) Deviations | Nationwide |